Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| STAA | NASDAQ | STAAR Surgical Company | $26.44 | -8.76% | 489K | $1.16B |
| COLL | NASDAQ | Collegium Pharmaceutical, Inc. | $36.08 | -0.52% | 254K | $1.14B |
| CAPR | NASDAQ | Capricor Therapeutics, Inc. | $19.70 | -0.66% | 2.5M | $1.14B |
| SPTX | NASDAQ | Seaport Therapeutics, Inc. Common Stock | $21.00 | +2.19% | 54K | $1.13B |
| SVRA | NASDAQ | Savara Inc. | $5.51 | -4.17% | 1.6M | $1.13B |
| DRTS | NASDAQ | Alpha Tau Medical Ltd | $12.71 | -2.08% | 365K | $1.13B |
| DRTSW | NASDAQ | Alpha Tau Medical Ltd. | $3.18 | -10.17% | 30K | $1.13B |
| FBRX | NASDAQ | Forte Biosciences, Inc. | $54.78 | -8.24% | 576K | $1.12B |
| WVE | NASDAQ | Wave Life Sciences Ltd. | $5.81 | +0.52% | 2.1M | $1.12B |
| CRVS | NASDAQ | Corvus Pharmaceuticals, Inc. | $13.07 | -4.46% | 956K | $1.1B |
| QDEL | NASDAQ | QuidelOrtho Corporation | $16.05 | -3.20% | 913K | $1.09B |
| MGTX | NASDAQ | MeiraGTx Holdings plc | $11.77 | -2.73% | 497K | $1.09B |
| CGEM | NASDAQ | Cullinan Therapeutics, Inc. | $17.10 | -1.04% | 317K | $1.05B |
| LMRI | NASDAQ | Lumexa Imaging Holdings, Inc. Common Stock | $12.00 | -1.48% | 242K | $1.05B |
| CRON | NASDAQ | Cronos Group Inc. | $2.81 | +2.55% | 1.2M | $1.05B |
| ALVO | NASDAQ | Alvotech | $3.06 | -3.77% | 584K | $1.03B |
| GDRX | NASDAQ | GoodRx Holdings, Inc. | $2.96 | +3.14% | 530K | $1.03B |
| EYPT | NASDAQ | EyePoint Pharmaceuticals, Inc. | $12.19 | -2.25% | 1.5M | $1.02B |
| OLMA | NASDAQ | Olema Pharmaceuticals, Inc. | $11.70 | -0.34% | 807K | $1.02B |
| PCRX | NASDAQ | Pacira BioSciences, Inc. | $25.88 | -0.19% | 425K | $1.02B |
| LXRX | NASDAQ | Lexicon Pharmaceuticals, Inc. | $2.29 | -0.43% | 1.7M | $1.02B |
| LBRX | NASDAQ | LB Pharmaceuticals Inc Common Stock | $31.41 | +2.68% | 334K | $1B |
| NUTX | NASDAQ | Nutex Health, Inc. | $145.87 | -5.01% | 133K | $1B |
| PRCT | NASDAQ | PROCEPT BioRobotics Corporation | $20.89 | +5.77% | 1.9M | $949.98M |
| JANX | NASDAQ | Janux Therapeutics, Inc. | $15.78 | -2.23% | 550K | $934.89M |
| KURA | NASDAQ | Kura Oncology, Inc. | $10.39 | -0.57% | 1.1M | $922.37M |
| OPK | NASDAQ | OPKO Health, Inc. | $1.22 | +4.27% | 2.5M | $921.21M |
| PHAT | NASDAQ | Phathom Pharmaceuticals, Inc. | $11.44 | -1.38% | 936K | $912.41M |
| GERN | NASDAQ | Geron Corporation | $1.42 | -2.07% | 3.3M | $910.96M |
| FSHCX | NASDAQ | Fidelity Select Health Care Svcs Port | $122.50 | +0.57% | 0 | $891.24M |
| PHAR | NASDAQ | Pharming Group N.V. | $12.62 | -4.21% | 5K | $890.94M |
| SANA | NASDAQ | Sana Biotechnology, Inc. | $3.15 | -0.63% | 2.3M | $884.97M |
| CLYM | NASDAQ | Climb Bio, Inc. | $12.84 | +0.63% | 666K | $875.49M |
| ALVOW | NASDAQ | Alvotech | $0.13 | -23.53% | 1K | $874.33M |
| TBPH | NASDAQ | Theravance Biopharma Inc | $16.86 | 0.00% | 652K | $873.82M |
| TALK | NASDAQ | Talkspace, Inc. | $5.21 | -0.19% | 1.1M | $872.74M |
| INMD | NASDAQ | InMode Ltd. | $15.28 | +1.80% | 419K | $871.98M |
| ABUS | NASDAQ | Arbutus Biopharma Corp | $4.80 | -6.61% | 876K | $865.22M |
| ANNX | NASDAQ | Annexon, Inc. | $5.22 | -1.51% | 2.7M | $855.24M |
| AMPH | NASDAQ | Amphastar Pharmaceuticals, Inc. | $19.75 | -0.58% | 446K | $825.42M |
| BIOA | NASDAQ | BioAge Labs Inc. | $21.77 | -0.59% | 1M | $819.63M |
| REPL | NASDAQ | Replimune Group, Inc. | $9.70 | -7.27% | 3.3M | $814.27M |
| BVS | NASDAQ | Bioventus Inc. | $11.88 | -2.78% | 473K | $799.43M |
| HSTM | NASDAQ | HealthStream, Inc. | $27.14 | +2.82% | 177K | $792.75M |
| SLDB | NASDAQ | Solid Biosciences Inc. | $7.83 | -1.88% | 1.1M | $770.86M |
| CSTL | NASDAQ | Castle Biosciences, Inc. | $24.51 | +2.57% | 409K | $748.69M |
| SIBN | NASDAQ | SI-BONE, Inc. | $16.62 | +0.91% | 381K | $737.09M |
| MNPR | NASDAQ | Monopar Therapeutics Inc. | $109.87 | +3.95% | 230K | $736.03M |
| DSGN | NASDAQ | Design Therapeutics, Inc. | $12.57 | -0.32% | 417K | $735.74M |
| ACRS | NASDAQ | Aclaris Therapeutics, Inc. | $5.23 | -4.56% | 761K | $730.42M |